By: Cognex Corp.
07/15/2011
Since 1975, the Food and Drug Administration (FDA) has required that all prescription tablets or capsules have a unique identification in terms of size, shape, color, and imprint. Drug makers use the imprints both to identify the chemical substance and dosage and for promotional purposes. Acceptable identification has traditionally been achieved by printing, debossing, or embossing. Debossing is pushing the image below the surface level of the product, and embossing is pushing the image above the surface level of the product.